Abstract
ObjectivesTo assess the real-world effectiveness and safety of sodium-glucose co-transporter-2 inhibitors (SGLT2i) on cardiovascular outcomes in patients with type 2 diabetes mellitus (T2D) and heart failure (HF) and to evaluate...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have